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BACKGROUND. Morphological patterns of Paneth cells are a prognostic biomarker in Western
Crohn’s disease (CD) patients, and are associated with autophagy-associated ATG16L1 and NOD2
variants. We hypothesized that genetic determinants of Paneth cell phenotype in other ethnic CD
cohorts are distinct but also involved in autophagy.
METHODS. We performed a hypothesis-driven analysis of 56 single nucleotide polymorphisms
(SNPs) associated with CD susceptibility or known to affect Paneth cell function in 110 Japanese CD
patients who underwent ileal resection. We subsequently performed a genome-wide association
analysis. Paneth cell phenotype was determined by defensin-5 immunofluorescence. Selected
genotype–Paneth cell defect correlations were compared to a Western CD cohort (n = 164).
RESULTS. The average percentage of abnormal Paneth cells in Japanese CD was similar to Western
CD (P = 0.87), and abnormal Paneth cell phenotype was also associated with early recurrence (P
= 0.013). In contrast to Western CD, ATG16L1 T300A was not associated with Paneth cell defect
in Japanese CD (P = 0.20). Among the 56 selected SNPs, only LRRK2 M2397T showed significant
association with Paneth cell defect (P = 3.62 × 10–4), whereas in the Western CD cohort it was not
(P = 0.76). Pathway analysis of LRRK2 and other candidate genes with P less than 5 × 10–4 showed
connections with known CD susceptibility genes and links to autophagy and TNF-α networks.
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CONCLUSIONS. We found dichotomous effects of ATG16L1 and LRRK2 on Paneth cell defect
between Japanese and Western CD. Genes affecting Paneth cell phenotype in Japanese CD were also
associated with autophagy. Paneth cell phenotype also predicted prognosis in Japanese CD.
FUNDING. Helmsley Charitable Trust, Doris Duke Foundation (grant 2014103), Japan Society for
the Promotion of Science (KAKENHI grants JP15H04805 and JP15K15284), Crohn’s and Colitis
Foundation grant 274415, NIH (grants 1R56DK095820, K01DK109081, and UL1 TR000448).

Introduction
Crohn’s disease (CD) and ulcerative colitis are 2 main classical types of inflammatory bowel disease (IBD)
(1, 2). The etiology of IBD involves genetic susceptibility and environmental triggers. Over 200 single
nucleotide polymorphisms (SNPs) have been associated with susceptibility to IBD (3–7). This complex
genetic network indicates that IBD likely encompasses more than the 2 classical subtypes. Therefore,
novel, rationally designed biomarkers that can lead to disease stratification and personalized treatments
are needed (8). One candidate method to subtype CD is to define the morphological patterns of small
intestinal Paneth cells based on the intracellular distribution of granules containing antimicrobial proteins (Paneth cell phenotypes) (7). Paneth cells are specialized secretory cells located at the bases of the
crypts of Lieberkühn in the small intestine (9–11). These cells produce a wide repertoire of antimicrobial
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peptides, such as lysozyme and α-defensins, to modulate
the intestinal microbiome (12–15) and thus are important
mediators of the host innate immune response (16, 17).
We have previously shown that in European ancestry
CD patients from North America, abnormal Paneth cell
phenotype is associated with variants in ATG16L1 and
NOD2 genes, both of which are CD susceptibility genes
involved in autophagy (18, 19). Furthermore, we have
also demonstrated that abnormal Paneth cell phenotype
is associated with mucosal dysbiosis and aggressive disease course (19, 20). Thus, Paneth cell phenotype is a
biologically and clinically relevant biomarker that can
stratify CD patients.
To broaden the applications of Paneth cell phenotype in CD, a more detailed understanding of the genetic determinants of Paneth cell phenotype and further
clinical validation are critical. However, as over 90% of
Western CD cases are composed of patients of European ancestry who harbor ATG16L1 T300A and/or NOD2
CD-risk variants (3, 4), identification of novel genetic
Figure 1. Diagram of the genetic–
determinants in this population is challenging. Thus,
Paneth cell analysis in Japanese
Crohn’s disease patients. CD, Crohn’s studying CD patients from other ethnicities, especially
those who possess a spectrum of susceptibility genes disdisease; MAF, minor allele frequency.
tinct from those found in European ancestry CD, would
be helpful in identifying novel genetic determinants of
Paneth cell phenotype. The genetic landscape of CD
patients from Korea and Japan is partially overlapping
but largely different than that of European ancestry CD
(5, 21–23). In particular, the NOD2 variants associated
with European ancestry CD are not polymorphic in
Japanese populations (24). In addition, while ATG16L1
T300A is polymorphic in Japanese cohorts, it has not
been associated with CD susceptibility (25). In contrast, SNPs that are more frequently associated with
CD in Asian populations include those that tag TNFSF15, IL23R, ATG16L2, STAT3, GPR35, MHC Class
II, and ZNF365, among others (5, 21–23, 25). Therefore, a Japanese CD patient cohort represents a
unique cohort to identify novel genetic determinants of Paneth cell phenotypes.
In this study, we hypothesized that novel genetic determinants of Paneth cell defect exist in Japanese CD,
and that abnormal Paneth cell phenotype would be associated with poor outcome in Japanese CD patients. We
further hypothesized that these novel genetic determinants of Paneth cell defect in Japanese CD would also be
associated with autophagy as in North American CD. We found that the prevalence of abnormal Paneth cell
phenotype in Japanese CD was similar to North American CD. Abnormal Paneth cell phenotype also correlated with more aggressive outcome in Japanese CD. Our hypothesis-driven analysis identified that autophagyassociated LRRK2, but not ATG16L1, was associated with Paneth cell defect in Japanese CD. In contrast, in
North American CD, ATG16L1 but not LRRK2 was associated with Paneth cell defect. In addition, unbiased
genome-wide analysis for Paneth cell phenotype genetic associations identified additional candidate SNPs predicted to interact with known CD susceptibility genes and jointly affect autophagy or TNF-α signaling.

Results
Paneth cell defects were prevalent in Japanese CD patients. The overall work flow for the determination of genetic
associations of Paneth cell defect in Japanese CD patients is outlined in Figure 1. We first determined the
percentage of normal Paneth cells in resection specimens of adult Japanese CD subjects using a previously
reported method of immunofluorescence localization for defensin-5 (20). The staining for defensin-5 was
specific for Paneth cells and the results were highly correlative to that obtained by lysozyme immunofluorescence (R2 = 0.6451; P < 0.0001) (Supplemental Figure 1; supplemental material available online with this
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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Figure 2. Type I Paneth cell phenotype was
prevalent in Japanese Crohn’s disease (CD). (A)
Representative images of defensin-5 immunofluorescence on Japanese CD resection specimens.
Scale bar: 10 μm. (B) The distribution of percentage of normal Paneth cells in North American
(n = 164) and Japanese CD (n = 110). P = 0.87 by
unpaired t test. Error bars represent ± SEM.

article; https://doi.org/10.1172/jci.insight.91917DS1). There was a similar range of intracellular staining
patterns to those previously observed in multiple North American CD cohorts (19, 20) (Figure 2A). The
average percentage of normal Paneth cells was similar between Japanese and North American CD subjects
(82.13 ± 1.06 vs. 81.9 ± 0.55; P = 0.87) (Figure 2B). As in previous studies, we utilized a cutoff of greater
than or equal to 20% (high abundance) abnormal Paneth cells to define a type I Paneth cell phenotype
(type II is < 20% abnormal Paneth cells). We found that the prevalence of type I Paneth cell phenotype in
Japanese CD subjects was similar to a North American cohort (33% vs. 26%; P = 0.26) (Figure 2B). We
also examined potential correlations between the clinical data obtained for the Japanese CD subjects and
Paneth cell phenotypes (Table 1). Of note, there was no significant difference in the demographics and
clinical phenotype (Montreal classification) between patients with type I and type II Paneth cell phenotypes
at time of resection. In addition, we also examined whether Paneth cell phenotype and/or individual morphology category correlated with the presence or absence of granuloma. We found that while there was a
trend in that the percentage of diminished Paneth cell morphology inversely correlated with the presence of
granuloma as we have shown previously (19), overall there was no significant correlation between Paneth
cell phenotype or each Paneth cell morphology category and granuloma (Supplemental Figure 2).
Type I Paneth cell phenotype was associated with poor clinical outcome in Japanese CD. To determine whether
Paneth cell phenotype also correlated with clinical outcome in patients undergoing resections in Japanese
CD, we analyzed the clinical outcome only for those patients who had received postoperative prophylactic
therapy, as postoperative prophylaxis has been shown to be associated with outcome (26). We listed the
characteristics of the patients that were included for outcome analysis in Supplemental Table 1. We found
that in Japanese CD patients, type I Paneth cell phenotype was also associated with shorter time to disease
recurrence after resection (P = 0.013; hazard ratio = 2.10, 95% CI = 1.04–4.24) (Figure 3). This association
remained significant in multivariate analysis (Supplemental Table 2), thus replicating the finding that we
have previously shown in North American CD patients (19).
ATG16L1 T300A was not associated with Paneth cell defect in Japanese CD. We next examined the potential
associations of type I Paneth cell phenotype with 56 SNPs, selected based on known CD susceptibility associations (3, 5, 21–23, 27–29) or known association with Paneth cell function (17) (Supplemental Table 3). These
SNPs include coding variants for ATG16L1 (T300A) associated with Paneth cell defects in North American
CD cohorts and in genetic mouse models (18, 19, 30). Among the Japanese CD patients with available genotype data (n = 98), we found no significant difference between the numbers of the ATG16L1 T300A risk allele
and the percentage of normal Paneth cells (R2 = 0.01717; P = 0.20) (Figure 4A). In contrast, in North American CD with wild-type NOD2 (to eliminate potential confounding factors from NOD2; n = 97), the numbers
of ATG16L1 T300A risk allele correlated with the percentage of normal Paneth cells (R2 = 0.04387; P =
0.0395; Figure 4B), a finding that we have shown previously with a smaller CD cohort (18). Of note, the allele
frequency of ATG16L1 T300A in our Japanese CD cohort was 40%, a level comparable to what has been
published (27). Therefore, in contrast to the North American CD, ATG16L1 T300A was not associated with
the percentage of normal Paneth cells or type I Paneth cell phenotype in Japanese CD. NOD2, another CD
susceptibility gene previously shown to be associated with Paneth cell defect in North American CD patients,
is nonpolymorphic in Japanese patients (31, 32), and thus was not included on the Japonica SNP array.
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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Table 1. Characteristics of all Japanese Crohn’s disease patients included in this study
Type I Paneth cell phenotype

Type II Paneth cell phenotype

P value

31
22 (71.0%)
17.5 (14.8–20.3)
23.8 (21.5–26.2)

79
60 (76.0%)
18.0 (16.2–19.7)
23.1 (21.7–24.6)

0.630
0.786
0.612

4 (12.9%)
26 (83.9%)
1 (3.2%)

11 (13.9%)
67 (84.8%)
1 (1.3%)

1.000
1.000
0.486

3 (9.7%)
0
28 (90.3%)

12 (15.2%)
0
67 (84.8%)

0.550
NA
0.550

0
25 (80.7%)
20 (64.5%)
24 (80%)
9 (36%)

1 (1.3%)
74 (93.6%)
36 (45.6%)
59 (75.6%)
16 (32%)

1.000
0.071
0.090
0.800
0.798

12 (38.7%)
5 (16.1%)
12 (38.7%)

22 (27.9%)
7 (8.9%)
18 (22.8%)

0.359
0.313
0.102

5 (16.1%)
0
6 (19.4%)
1 (3.2%)
2 (6.5%)
0
4 (12.9%)

13 (16.5%)
2 (2.5%)
13 (16.5%)
4 (5.1%)
4 (5.2%)
0
1 (1.3%)

1.000
1.000
0.781
1.000
1.000
NA
0.022

7 (22.6%)
16 (51.6%)
10 (32.3%)
6 (19.4%)
13 (41.9%)

27 (34.2%)
35 (44.3%)
20 (25.3%)
12 (15.2%)
26 (32.9%)

0.262
0.529
0.482
0.579
0.385

9 (29.0%)
1 (3.2%)
5 (16.1%)
1 (3.2%)
4 (12.9%)
2 (6.5%)
2 (6.5%)

17 (21.5%)
2 (1.8%)
14 (17.7%)
7 (8.9%)
9 (11.4%)
1 (1.3%)
2 (2.5%)

0.457
1.000
1.000
0.437
1.000
0.191
0.315

n
Sex (male)
Mean disease duration in years (range)
Mean age at onset (range)
Disease OnsetA
A1
A2
A3
Disease Location
L1
L2
L3
Disease Behavior
B1
B2
B3
Perianal disease
Current smoking
Treatment received prior to surgery
Biologics (Bio)
Immunomodulator (IM)
Elemental diet (ED)
Treatment combination prior to surgery
Only Bio
Only IM
Only ED
Bio+IM
Bio+ED
ED+IM
Bio+IM+ED
Postoperative therapy
None
Bio
First use of Bio
IM
ED
Treatment combination
Only Bio
Only IM
Only ED
Bio+IM
Bio+ED
ED+IM
Bio+IM+ED

Disease onset, location, and behavior are reported according to the Montreal classification.

A

Western CD susceptibility allele LRRK2 M2397T was associated with Paneth cell defect in Japanese CD. Interestingly, the only SNP within the pool of 56 selected alleles for hypothesis-driven correlation analysis that
showed significant association with Paneth cell defects in Japanese CD was LRRK2 M2397T (Figure 4C).
The LRRK2 M2397T SNP (rs3761863) is a missense susceptibility allele for European ancestry CD (3, 33),
and Lrrk2 knockout mice have defective Paneth cells (34). In the Japanese CD cohort, we found that the
numbers of the T (risk) allele LRRK2 M2397T correlated with the percentage of normal Paneth cells (R2 =
0.247; P = 3.62 × 10–4; Figure 4C). The results suggest that 2 defective copies of the LRRK2 gene product
may be required to illicit Paneth cell defects in Japanese CD patients.
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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Figure 3. Paneth cell phenotypes correlated with time to disease recurrence after surgery in Japanese Crohn’s disease (CD). The Kaplan-Meier curves of time to disease recurrence after resection was
determined in the CD cases that received prophylaxis after surgery (n = 76). Patients with type I Paneth
cell phenotype showed a significantly shorter time to disease recurrence (P = 0.013 by log-rank test).

To determine whether this correlation was universal, we next analyzed the correlation of LRRK2 M2397T and Paneth cell defects in the North American CD cohort (with
wild-type NOD2 as described above). Surprisingly, there was no association between
the numbers of LRRK2 M2397T risk allele and the degree of Paneth cell defect (R2 =
0.02054; P = 0.76; Figure 4D). As ATG16L1 T300A and NOD2 SNPs are known to be
associated with Paneth cell defects in North American CD cohorts, we performed further
analyses with the North American CD patients with ATG16L1 T300A and/or NOD2 risk
alleles (n = 116 with LRRK2 M2397T status available) as well as the patients without any
risk alleles for ATG16L1 T300A or NOD2 (n = 15 with LRRK2 M2397T status available).
There was no association of LRRK2 M2397T and the percentage of normal Paneth cells when all patients
(including ATG16L1 T300A and/or NOD2 risk alleles) were analyzed (P = 0.13; Supplemental Figure 3A)
or when only the subset of patients without ATG16L1 T300A and NOD2 risk alleles were analyzed (P =
0.82; Supplemental Figure 3B). However, given the relatively small sample size with wild-type ATG16L1
T300A and NOD2, further investigation with a greater sample size is needed. Therefore, our data suggest
that there are dichotomous effects of the ATG16L1 and LRRK2 susceptibility alleles on Paneth cell defects
within Japanese and North American CD cohorts. Interestingly, LRRK2 M2397T itself was not associated
with outcome (P = 0.5931) (Supplemental Table 2).
Unbiased genome-wide association identified additional candidate genes associated with Paneth cell defect in Japanese
CD. We subsequently performed an unbiased GWAS analysis to identify additional potential novel SNPs that
could be associated with the degree of Paneth cell defects. Although no SNPs reached genome-wide significance (<5 × 10–8), 45 SNPs were identified as candidates (P ≤ 5 × 10–6), as well as 8 nonsynonymous SNPs

Figure 4. ATG16L1 T300A and LRRK2 M2397T
genotypes showed dichotomous effects on Paneth
cell defects in Japanese and North American Crohn’s
disease (CD) patients. (A) The numbers of the
ATG16L1 T300A risk allele did not correlate with the
percentage of normal Paneth cells (R2 = 0.01717 and P
= 0.20 by linear regression) in Japanese CD, while (B)
in North American CD without the common CD-associated NOD2 risk allele, the numbers of the ATG16L1
T300A risk allele correlated with the percentage of
normal Paneth cells (R2 = 0.04387 and P = 0.0395 by
linear regression). In contrast, (C) the numbers of the
LRRK2 M2397T risk allele negatively correlated with
the percentage of normal Paneth cells in Japanese CD
(R2 = 0.247, P = 3.62 × 10–4 by linear regression). (D)
However, in North American CD, the numbers of the
LRRK2 M2397T risk allele did not correlate with the
percentage of normal Paneth cells (R2 = 0.02054, P =
0.76 by linear regression). Error bars represent ± SEM.
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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Figure 5. Genome-wide association analysis results for Paneth cell defect in Japanese Crohn’s disease (CD) patients. Locus zoom plots of P values
around selected top associated SNPs from Paneth cell phenotype regression analysis. The top associated SNPs for (A) ZBTB16, (C) MAFB, and (E) FER
are shown as purple diamonds and the remaining SNPs are shown as circles, with color indicating the level of linkage disequilibrium (R2) with lead SNP.
(B, D, and F) Corresponding normal Paneth cells–numbers of risk alleles correlation. Error bars represent ± SEM. (B) P = 2.74 × 10–6; (D) P = 5.11 × 10–7; (F)
P = 7.22 × 10–7; all by linear regression.

insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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Figure 6. Ingenuity pathway analysis of the genes associated with Paneth cell defect in Japanese Crohn’s disease (CD)
patients. The genes include LRRK2 and the candidate genes
listed in Table 2 and Supplemental Table 4. The intensity of
the color correlates with the P values. Solid lines indicate
direct interactions, and dotted lines indicate indirect interactions. Red denotes genes associated with Paneth cell defect
in Japanese CD (intensity positively correlates with P values).
Blue denotes inflammatory bowel disease susceptibility genes.
The majority of the genes associated with Paneth cell defect
are involved in (A) the PI3K/mTOR pathway, which links to
autophagy, whereas a minor subset of the genes are involved
in (B) TNF signaling.

that had P values less than or equal to 5 × 10–4 (Supplemental Figure 4). The candidate SNPs were categorized
into 9 gene regions (Table 2 includes the 9 top-associated
SNPs in these regions). Among the 9 candidate genes,
ZBTB16, MAFB, and FER (Figure 5) were of particular
interest. ZBTB16 modulates autophagy by degrading
Atg14 (35). MAFB is an important transcriptional factor
for macrophage differentiation (36), and FER plays a role
in neutrophil chemotaxis (37), both of which are involved
in innate immunity and plausibly affect autophagy functions (38, 39). Therefore, genes involved in autophagy
and innate immunity are candidates for the development
of Paneth cell defect in Japanese CD. Further studies in
additional cohorts are needed to confirm or refute these
findings. Supplemental Table 4 shows the top functional
or nonsynonymous SNPs associated with Paneth cell
defect (P ≤ 5 × 10–4).
Pathway analysis revealed association with autophagy
and inflammatory cytokines in candidate genes associated
with Paneth cell defect. To determine the spectrum of
pathways involved in the genes associated with Paneth cell defect in Japanese CD, we first performed gene
enrichment, protein interaction, and KEGG pathway
analyses to explore the biological functions of the top
annotated genes corresponding to SNPs associated
with abnormal Paneth cells with P values less than or
equal to 1 × 10–3 (n = 288) to obtain an overview of
these pathways. Our results demonstrate that the gene
list was enriched for specific molecular functions and
biological pathways that could be related to Paneth cell
phenotype. Twelve functional annotation clusters with an enrichment score of E greater than 1.4 (corresponding to unadjusted P value of 0.05) were identified for this gene set (Supplemental Table 5). We
also used the 288-gene list to generate a protein-protein interaction network (Supplemental Table 6). The
functional annotation of the network is shown in Supplemental Figure 5 and the KEGG pathways (P <
0.05) for these genes are listed in Supplemental Table 7. Many of the pathways and networks, such as cell
adhesion and cytoskeletal remodeling, are known to be linked to IBD pathogenesis (4).
We next focused our analysis on the 17 identified candidate genes (LRRK2 and genes described in Table 2
and Supplemental Table 4). Ingenuity pathway analysis showed that the 17 genes identified can be connected
in 2 distinct networks (Figure 6). The majority are involved in a gene network regulating PI3K and ERK
signaling pathways (Figure 6A). Both of these pathways can regulate the mTOR pathway, a known upstream
regulator of autophagy (40, 41). Moreover, in previous studies, mTOR signaling has been linked to stem cell
health and Paneth cell differentiation (42–44). A second subset of genes were linked to the TNF-α signaling
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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Table 2. Candidate SNPs and genes associated with Paneth cell defect in Japanese Crohn’s disease by GWAS (P ≤ 5 × 10–6)
dbSNP

Chr

PositionA (bp)

Allele1/2

P value

Beta

Gene

Location

rs12481514
rs723080
rs147629807
rs17318450
rs12494894
rs629922
rs72622838
rs11978753
rs2238823

20
20
5
5
3
11
8
7
22

4225920
39357465
107889038
35482314
158596415
114064825
72100325
152717110
45936320

A/G
C/T
-/T
A/G
A/G
C/T
A/G
G/T
A/G

2.52 × 10–7
5.11 × 10–7
7.22 × 10–7
1.62 × 10–6
2.25 × 10–6
2.74 × 10–6
3.04 × 10–6
3.65 × 10–6
3.80 × 10–6

4.469
−4.754
−8.139
−5.826
−6.381
4.142
−4.181
−5.941
−5.626

ADRA1D
MAFB
FER
PRLR
MFSD1
ZBTB16
EYA1
ACTR3B
FBLN1

intronic
upstream
upstream
upstream
downstream
intronic
downstream
downstream
intronic

Positions are based on the Genome Reference Consortium human build 37 (GRCh37). Chr, chromosome.

A

pathway (Figure 6B), consistent with the central role of TNF-α in IBD pathogenesis (4, 6, 45). TNF-α has also
been implicated in the homeostasis of Paneth cell function (46–49). Therefore, the candidate genes for Paneth
cell dysfunction in Japanese CD patients potentially act through modulating autophagy and TNF-α signaling.
We also examined the potential interactions between the 17 identified genes and known CD susceptibility
genes (6). We found interactions with several IBD susceptibility genes in both networks (6). For example, IBD
susceptibility genes FYN, HCK, HNF4A, MAPK1, and RPS6KB1 were involved in the PI3K network, which
included genes MAFB, ADRA1D, PRLR, ACTR3B, CEP192, CAND2, FOXM1, MFSD1, and RP1L1 that were
identified in this study. Likewise, IBD susceptibility genes IFNG, IL6ST, LRRK2, and CEBPB, as well as genes
identified in this study LRRK2, ZBTB16, FBLN1, and EYA1, were involved in the TNF-α network. Therefore,
the genes identified in this study potentially act in concert with known IBD susceptibility genes in autophagy
and TNF-α signaling networks in association with Paneth cell defect.

Discussion
We have previously shown that Paneth cell phenotypes are associated with CD susceptibility alleles, pathological hallmarks, unique transcriptomic and mucosal microbiome changes, and outcome in patients
undergoing surgery in North American CD (19, 20). However, it was unclear whether similar associations
would be present in CD patients from different genetic/ethnic backgrounds, particularly as the incidence of
CD in other ethnic groups has continued to rise (50, 51). In the current study, we first set out to determine
the prevalence, and the genetic and clinical associations, of Paneth cell defect in Japanese CD, a population
who possess a distinct spectrum of susceptibility genes compared with European ancestry CD. We demonstrated that not only was Paneth cell defect prevalent in the Japanese CD, clinically it also correlated with
prognosis in Japanese CD patients after surgery. Surprisingly, there were dichotomous effects of ATG16L1
and LRRK2 between the 2 cohorts. We also identified several associated SNPs in genes linked to autophagy
and TNF-α signaling as candidates for Paneth cell defect in the Japanese CD.
While ATG16L1 T300A was associated with defective Paneth cells in both mouse models and North
American adult CD patient cohorts (18, 52, 53), this genetic association was not observed in Japanese CD.
In contrast, we found that LRRK2 M2397T, a susceptibility allele for European ancestry but not for Japanese or Korean CD (3, 23, 25, 33, 54), was associated with Paneth cell defect in Japanese, but not North
American CD. There are several important considerations when interpreting these findings. First, given the
different allele frequencies of ATG16L1 T300A between European and Asian CD cohorts (5), it is possible
that a larger sample size is required to achieve sufficient power to detect an association between ATG16L1
T300A with Paneth cell defect in Japanese CD. Second, while LRRK2 M2397T is not a susceptibility allele
for Japanese CD, it could also represent a power issue in the Japanese populations. In addition, it is possible
that LRRK2 M2397T, a missense variant that could result in functional defect of LRRK2, may be associated
with other aspects of CD manifestations. A recent study in leprosy (a granulomatous disease) showed that
patients harboring the same LRRK2 M2397T allele suffer from excessive proinflammatory responses (55).
Interestingly, overlapping susceptibility loci between CD and mycobacterial infection (particularly leprosy) is
established (3). A longitudinal study would provide additional insight into the clinical relevance of LRRK2
M2397T in Japanese CD. Additional advanced sequencing technologies such as fine mapping and deep
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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sequencing of the LRRK2 gene and expression quantitative trait loci analysis will be important to validate
the association of the M2397T SNP with Paneth cell defect, as has been shown in other studies (22, 29).
Using mouse models, we previously showed that Paneth cell defect is the result of gene and environment interactions, suggesting that proper environmental triggers or genetic context may be required to illicit
Paneth cell defect in CD patients. The sharp contrast of divergent correlations of ATG16L1 T300A and
LRRK2 M2397T with Paneth cell defects in North American and Japanese CD cohorts suggests that the
environmental factors that the North American and Japanese CD patients harboring these variants encountered could be distinct. Furthermore, based on our current understanding of the autophagy machinery, in
complex biologic processes such as Paneth cell function and intestinal homeostasis, the functions of these
autophagy-associated genes may need to be orchestrated in distinct fashions depending on the environmental insults unique to these populations (56). One important direction is to use Paneth cell phenotype
analysis as a platform to identify potential environmental factors or additional genetic factors that interact
with specific host mutants in triggering Paneth cell defect in CD patients and mouse models with LRRK2
deficiency. In addition, environmental and genetic factors that could exert a protective effect of Paneth
cell defect should be investigated through large-scale studies. Also of particular interest is to compare the
Paneth cell phenotype in first- and second-generation Asian immigrants to North America (and vice versa),
an approach that has yielded insight into disease pathogenesis in epidemiological studies (57–60). Based
on our finding, we predict that while the genetic landscape of the second-generation immigrants will be
similar to their parents, the genetic correlation to Paneth cell defects will trend more toward European
ancestry North American CD. In addition, conducting genetic–Paneth cell defect analysis with focused
ethnic groups (e.g., Ashkenazi Jewish) (61, 62) and with cross-ethnic groups (5) may provide additional
insight into potential gene-gene interactions in triggering Paneth cell defect.
Among the candidate genes shown to be associated with Paneth cell defects by hypothesis-free association, ZBTB16, MAFB, and FER have been shown to be linked to autophagy and components of the innate
immune response that could be modulated with autophagy. ZBTB has been shown to regulate autophagy by
mediating the proteasomal degradation of Atg14L (35). ZBTB16 is also involved in type 2 innate lymphoid
cell function (63), NKT cell differentiation (64), and regulation of inflammatory signaling (65). MAFB is
associated with macrophage differentiation (36, 66). FER plays a role in leukocyte recruitment and intestinal
barrier function in response to bacterial lipopolysaccharide recognition (67). Both macrophage differentiation
and leukocyte recruitment are important elements of innate immunity and involves autophagy (38, 39). Thus,
the observation that genes involved directly and indirectly in autophagy were candidates for Paneth cell defect
supports the notion that autophagy is a central pathway that controls the intestinal homeostasis (68).
We and others have found that molecular changes in processes such as autophagy and TNF signaling
converge to affect Paneth cell function in CD patients and mouse models of intestinal inflammation (19,
45, 52, 69, 70). This in turn correlates with the development of dysbiosis and inflammation (20). Together,
these studies suggest that, at least in a subset of CD patients, Paneth cells are the origin of intestinal inflammation (10). Future studies that examine the transcriptomic and signaling pathways of Paneth cells from
patients with different genetic backgrounds will provide additional insight.
Importantly, although the SNPs for Paneth cell defect identified in this study were largely distinct from
the known SNPs for European ancestry CD, Paneth cell phenotype still correlated with prognosis in Japanese CD patients undergoing surgery. These results indicate that Paneth cell phenotype, as an integrated
readout for combinatorial effect of host genetics and environmental factors, could potentially be applied
as a universal prognostic biomarker for CD patients of different ethnicity/genetic backgrounds undergoing
resection. Of note, a recent study has highlighted that the genes associated with CD susceptibility and prognosis are distinct (71). Therefore, development of a potential gene score that predicts postoperative recurrence may be complementary to using Paneth cell phenotype as biomarker. In addition, while we did not
observe the correlation between Paneth cell phenotype and the presence of granuloma, we did observe a
trend between diminished Paneth cells and granuloma, a finding that was significant in our previous study
in North American CD (19). Therefore, future studies with a larger sample size may provide more insight.
In summary, we demonstrated that Paneth cell defect was prevalent in Japanese CD, was associated with
different spectrum of genes compared with North American CD, and was predictive of prognosis. The genes
involved in Paneth cell defect in Japanese CD mainly affect autophagy and TNF signaling pathways. Paneth
cell phenotype can be applied as a universal clinical and biological relevant biomarker for CD patients with
diverse genetic backgrounds.
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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Methods
Subjects. A total of 110 Japanese patients with CD were included in this study. All patients were diagnosed
with CD and underwent ileal resection at Tohoku University Hospital (Sendai, Japan) between 2003 and
2014. The self-reported ethnicity of all patients was Japanese. The diagnosis of CD was made based on
clinical symptoms and endoscopic, radiographic, and histological findings according to conventional criteria proposed by the Japanese Ministry of Health, Labour and Welfare (72). Demographics and clinical
parameters (including clinical phenotype by Montreal classification, medication received prior to and after
surgery, time to disease recurrence after resection) were extracted from the medical records blinded to Paneth cell phenotypes.
In addition, a total of 164 CD patients who underwent ileal resection were recruited at Washington
University School of Medicine between 2005 and 2013, including a subset of patients (n = 50) that were
previously reported (19).
Paneth cell phenotype analysis. Ileal resection samples previously collected as part of standard diagnostic
procedures and stored in Pathology Department archives at Tohoku University and Washington University were used for Paneth cell phenotype determination. The specimens were processed as formalin-fixed,
paraffin-embedded (FFPE) tissue blocks stored at 24°C as per routine surgical pathology practice. To be
included in the study, the proximal margin tissue resection samples must have contained at least 50 welloriented intestinal crypts (73) as determined by a pathologist (T.C.L.). Paneth cell phenotype was determined by defensin-5 immunofluorescence, using defensin-5 antibody (clone 8C8; dilution 1:2,000; Novus
Biologicals, catalog NB110) followed by donkey anti-mouse Alexa 488 antibody (dilution 1: 500; Thermo
Fisher Scientific, catalog A-21202) as previously described (20). For a subset of cases, costaining with
lysozyme immunofluorescence was performed using lysozyme antibody (clone C-19; dilution 1:100; Santa
Cruz Biotechnology, catalog sc-27958) followed by donkey anti-goat Alexa 594 antibody (dilution 1: 500;
Thermo Fisher Scientific, catalog A-11058). Each Paneth cell was classified as normal or abnormal based
on the morphology of the cytoplasmic granules (19, 20, 73). For prognostic correlation, the overall Paneth
cell phenotype for each patient was then defined as following: type I Paneth cell phenotype was defined
as greater than or equal to 20% abnormal Paneth cells, whereas type II Paneth cell phenotype was defined
as less than 20% abnormal Paneth cells (19, 20, 73). The cutoff of 20% was based on the analysis of 106
non-IBD cases, which showed that the mean percentage of normal Paneth cells was 80.63 (± 1.17 SEM).
The cutoff was used in our previous studies involving North American CD cohorts (19, 20, 73). Paneth
cell phenotype analysis was performed by a pathologist (T.C.L.) who was blinded to the identification and
clinical phenotype of the cases.
Definitions of clinical remission and clinical relapse. Time from index ileal resection surgery of CD to
relapse was calculated. Endoscopy and/or computed tomography were performed when the patients had
symptoms indicating recurrence (i.e., abdominal pain, worsening of diarrhea, fever, body weight loss, nausea, and appetite loss), or at least once per year if the patients had no symptoms.
Definitions of recurrence were made by endoscopy and/or radiology. Endoscopic recurrence was defined
as postoperative Rutgeerts score of i2 or more. Radiologic recurrence was defined by computed tomography
showing bowel wall thickening (defined as a thickness > 5 mm) or enhancement, fistulas, intra-abdominal
abscess, and bowel obstruction. All computed tomography scans were reviewed by 2 radiologists. Patients
who received immunomodulators (thiopurines), biologics (infliximab or adalimumab), or elemental diet
(more than 600 kcal/day) (74) after resection were considered to have received postoperative prophylaxis.
Genotyping. For Japanese CD patients, genomic DNA was obtained from peripheral blood leukocytes by standard phenol–chloroform extraction and precipitation or by utilizing an NA1000 Automated
Nucleic Acid Extraction Machine (Kurabo) or PAXgene DNA Kit (BD). The genome-wide SNP genotypes of the Japanese CD patients were determined by the Japonica array, a SNP array designed specifically for the Japanese population (75). The array contains 659,253 SNPs, including tag SNPs for imputation, as well as SNPs related to phenotypes from previously reported GWAS and pharmacogenomics
studies. As a part of quality control (QC) measures, SNPs with call rate less than 95% and samples
with genotyping rates less than 95% were excluded from further analysis. Following SNP and sample
QC, genotype data of 643,496 SNPs from 98 CD cases were available for further analysis. For North
American CD patients, genomic DNA was extracted from whole blood (n = 50) as described above or
from FFPE tissue using a QIAamp DNA FFPE Tissue kit (QIAGEN) (n = 114). For cases where whole
blood was used for genomic DNA extraction, genotyping was performed with Immunochip as previously
insight.jci.org   https://doi.org/10.1172/jci.insight.91917
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described (19). For cases where FFPE tissue was used for genomic DNA extraction, genotyping was
performed with Taqman SNP genotyping assays (Thermo Fisher Scientific).
Imputation. Untyped genotypes were imputed in the GWAS samples using IMPUTE2 (version 2.3.2)
and 1,070 healthy individuals from Japan (1KJPN panel, which contains > 20 million SNPs) (76) as a reference dataset. SNPs with low imputation quality (with a posterior probability score of < 0.90), minor allele
frequency less than 0.10 and Hardy-Weinberg equilibrium P value less than 1 × 10–5 were excluded. After
exclusion, genotype data of 4,198,245 SNPs from 98 Japanese CD cases were used for further analysis.
Pathway and network analysis. Gene enrichment and network analysis was performed on the top 288
annotated genes corresponding to the SNPs with P less than or equal to 1 × 10–3 (from linear regression)
using online bioinformatics tools DAVID (https://david.ncifcrf.gov/tools.jsp) and STRING (http://www.
string-db.org/). Functional annotation clusters corresponding to the gene list were identified using DAVID.
Protein-protein interaction (PPI) network for the 288 genes was extracted using STRING. An annotation network was constructed by combining function-based information with PPI network information
and visualized using Cytoscape (www.cytoscape.org). Corresponding pathways (P < 0.05) were annotated
using the enrichment analysis tool in STRING. Core pathway analysis of the 17 candidate genes was performed using Ingenuity Pathway Analysis software (QIAGEN).
Statistics. The percentages of normal Paneth cells between North American CD and Japanese CD were
compared by unpaired t test, and the prevalence of type I Paneth cell phenotype between the 2 groups
was compared using Fisher’s exact test. For genotype–Paneth cell defect correlation, we first adopted a
hypothesis-driven approach with selected SNPs (Figure 1). These SNPs include: (a) 45 SNPs shown to
have CD-specific susceptibility from an ImmunoChip study examining European ancestry CD (3); (b) an
additional 38 SNPs reported in European and East Asian ancestry CD (5); (c) 14 SNPs associated with
East Asian (Japanese and/or Korean) CD through GWAS analyses (21, 23, 28, 77) and deep-resequencing
analysis (22); and (d) 2 functional CD-associated variants that were either reported to be associated with
Paneth cell defect in our previous studies (18, 19), or whose genes involved had been implicated to be associated with Paneth cell biology in preclinical studies (17, 29). By excluding duplicates, a total of 73 SNPs
were compiled as candidates. Among the 73 SNPs, 14 SNPs were very rare (minor allele frequency < 1.0%)
or nonpolymorphic (i.e., NOD2 variants) in East Asian, and 3 SNPs were not constructed/included on
the Japonica array. After excluding these 17 SNPs, a final 56 SNPs were selected for the hypothesis-driven
approach. After Bonferroni correction, SNPs with P values less than 8.93 × 10–4 were considered significant. For hypothesis-driven analyses, we correlated the genotypes with the percentage of normal Paneth
cells by linear regression.
For the subsequent unbiased, GWAS analysis (Figure 1), linear regression was performed using PLINK
v1.07 software (78). SNPs with P values less than 5 × 10–8 were considered genome-wide significant. SNPs
with P values less than 5 × 10–6 and nonsynonymous SNPs with P values less than 5 × 10–4 were considered
candidates with nominal significance.
SNPs located within 100 kbp were considered to be in 1 region. Genes within 200 kbp of candidate
SNPs were investigated. Correlation with time to disease recurrence after surgery was performed using the
log-rank test and Cox-proportional hazards model. Manhattan plots were generated using the R package
qqman, regional association plots were generated using LocusZoom application (79). All statistical analyses, except genome-wide linear regression, were performed using JMP 11 (SAS Institute Inc.), GraphPad
Prism (version 6.5), or R software (version 3.1.3).
Power calculation. Using the software Quanto, we calculated the power of the current study to detect
genetic variants associated with the Paneth cell phenotype, and demonstrated that in the Japanese cohort,
we have a power of 80.66% to detect a variant with variance contribution of 0.07 at 0.05 significance
threshold for the hypothesis-driven approach. In the Washington University cohort, we have a power of
82.65% to detect a variant with variance contribution of 0.05 with a significance threshold of 0.05. At
genome-wide significance threshold (5 × 10–8), the Japanese cohort has a power of 56.91% to detect a variant with variance contribution of 0.247.
Study approval. The study was approved by the Ethics Committee of Tohoku University Graduate School
of Medicine under protocol number 2013-1-539 and the IRB of Washington University School of Medicine
under protocol number 201209047. Subjects provided informed consent prior to their participation in the study.
Data depository. The accession number for the genotyping data deposition at NCBI Gene Expression
Omnibus repository is GSE90102.
insight.jci.org   https://doi.org/10.1172/jci.insight.91917

11

CLINICAL MEDICINE

Author contributions
TCL, TN, DPBM, Y. Kakuta, and TSS designed the study. TCL, TN, ZL, TH, Y. Kawai, MN, and Y.
Kakuta acquired data. TN, TS, and TK recruited patients. TCL, TN, ZL, KLV, TH, DL, DPPM, Y.
Kakuta, and TSS analyzed data. TCL, TN, DPBM, Y. Kakuta, and TSS drafted the manuscript. TN, KE,
and Y. Kinouchi provided samples.

Acknowledgments
The study was supported by the Helmsley Charitable Trust (D.P.B.M., T.S.S.), Doris Duke Charitable Foundation grant 2014103 (T.C.L.), Crohn’s and Colitis Foundation grant 274415, NIH grants 1R56DK095820
(D.P.B.M., T.S.S.) and K01DK109081 (K.L.V.), NIH/National Center for Advancing Translational Sciences (NCATS) grant UL1 TR000448 (T.C.L.), and Japan Society for the Promotion of Science KAKENHI
grants JP15H04805 and JP15K15284 (Y.K.). Computational resources for genotype imputation were provided by the Tohoku Medical Megabank Organization supercomputer system.
Address correspondence to: Thaddeus S. Stappenbeck or Ta-Chiang Liu, Department of Pathology and
Immunology, Washington University School of Medicine, 660 South Euclid Avenue, CB 8118, St. Louis,
Missouri 63110, USA. Phone: 314.362.4214; E-mail: stappenb@wustl.edu (T.S. Stappenbeck). Phone:
314.747.0343; E-mail: tliu27@wustl.edu (T.C. Liu). Or to: Yoichi Kakuta, Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo, Aoba, Sendai, 980-8574, Japan. Phone:
81.22.717.7171; E-mail: ykakuta@med.tohoku.ac.jp.

1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590–1605.
2. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606–1619.
3. Jostins L, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature.
2012;491(7422):119–124.
4. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307–317.
5. Liu JZ, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic
risk across populations. Nat Genet. 2015;47(9):979–986.
6. McGovern DP, Kugathasan S, Cho JH. Genetics of inflammatory bowel diseases. Gastroenterology. 2015;149(5):1163–1176.e2.
7. Liu TC, Stappenbeck TS. Genetics and pathogenesis of inflammatory bowel disease. Annu Rev Pathol. 2016;11:127–148.
8. Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology.
2011;140(6):1817–1826.e2.
9. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol.
2011;9(5):356–368.
10. Adolph TE, et al. Paneth cells as a site of origin for intestinal inflammation. Nature. 2013;503(7475):272–276.
11. Clevers HC, Bevins CL. Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol. 2013;75:289–311.
12. Salzman NH, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010;11(1):76–83.
13. Salzman NH, Chou MM, de Jong H, Liu L, Porter EM, Paterson Y. Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect Immun. 2003;71(3):1109–1115.
14. Wehkamp J, et al. Reduced Paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci USA. 2005;102(50):18129–18134.
15. Bevins CL, Stange EF, Wehkamp J. Decreased Paneth cell defensin expression in ileal Crohn’s disease is independent of inflammation, but linked to the NOD2 1007fs genotype. Gut. 2009;58(6):882–3; discussion 883.
16. Ouellette AJ. Paneth cells and innate mucosal immunity. Curr Opin Gastroenterol. 2010;26(6):547–553.
17. Kaser A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.
Cell. 2008;134(5):743–756.
18. Cadwell K, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature.
2008;456(7219):259–263.
19. VanDussen KL, et al. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn’s disease.
Gastroenterology. 2014;146(1):200–209.
20. Liu TC, et al. Paneth cell defects in Crohn’s disease patients promote dysbiosis. JCI Insight. 2016;1(8):e86907.
21. Yamazaki K, et al. A genome-wide association study identifies 2 susceptibility Loci for Crohn’s disease in a Japanese population. Gastroenterology. 2013;144(4):781–788.
22. Hong SN, et al. Deep resequencing of 131 Crohn’s disease associated genes in pooled DNA confirmed three reported variants
and identified eight novel variants. Gut. 2016;65(5):788–796.
23. Yang SK, et al. Genome-wide association study of Crohn’s disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut. 2014;63(1):80–87.
24. Nakagome S, et al. Population-specific susceptibility to Crohn’s disease and ulcerative colitis; dominant and recessive relative
risks in the Japanese population. Ann Hum Genet. 2010;74(2):126–136.
25. Hirano A, et al. Association study of 71 European Crohn’s disease susceptibility loci in a Japanese population. Inflamm Bowel
Dis. 2013;19(3):526–533.
26. Sorrentino D. State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. Nat Rev Gastroenterol Hepatol.

insight.jci.org   https://doi.org/10.1172/jci.insight.91917

12

CLINICAL MEDICINE

2013;10(7):413–422.
27. Hampe J, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in
ATG16L1. Nat Genet. 2007;39(2):207–211.
28. Yang SK, et al. Immunochip analysis identification of 6 additional susceptibility loci for Crohn’s disease in Koreans. Inflamm
Bowel Dis. 2015;21(1):1–7.
29. Trabzuni D, et al. Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus. PLoS ONE.
2013;8(8):e70724.
30. Cadwell K, et al. Virus-plus-susceptibility gene interaction determines Crohn’s disease gene Atg16L1 phenotypes in intestine.
Cell. 2010;141(7):1135–1145.
31. Inoue N, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123(1):86–91.
32. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483
Japanese patients with Crohn’s disease. J Hum Genet. 2002;47(9):469–472.
33. Franke A, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat
Genet. 2010;42(12):1118–1125.
34. Zhang Q, et al. Commensal bacteria direct selective cargo sorting to promote symbiosis. Nat Immunol. 2015;16(9):918–926.
35. Zhang T, et al. G-protein-coupled receptors regulate autophagy by ZBTB16-mediated ubiquitination and proteasomal degradation of Atg14L. Elife. 2015;4:e06734.
36. Aziz A, Soucie E, Sarrazin S, Sieweke MH. MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science. 2009;326(5954):867–871.
37. Khajah M, Andonegui G, Chan R, Craig AW, Greer PA, McCafferty DM. Fer kinase limits neutrophil chemotaxis toward end
target chemoattractants. J Immunol. 2013;190(5):2208–2216.
38. Chen P, Cescon M, Bonaldo P. Autophagy-mediated regulation of macrophages and its applications for cancer. Autophagy.
2014;10(2):192–200.
39. Kanayama M, Inoue M, Danzaki K, Hammer G, He YW, Shinohara ML. Autophagy enhances NFκB activity in specific tissue
macrophages by sequestering A20 to boost antifungal immunity. Nat Commun. 2015;6:5779.
40. Shanware NP, Bray K, Abraham RT. The PI3K, metabolic, and autophagy networks: interactive partners in cellular health and
disease. Annu Rev Pharmacol Toxicol. 2013;53:89–106.
41. Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett. 2010;584(7):1287–1295.
42. Zhou Y, Rychahou P, Wang Q, Weiss HL, Evers BM. TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation
in the intestinal epithelium. Cell Death Dis. 2015;6:e1631.
43. Igarashi M, Guarente L. mTORC1 and SIRT1 cooperate to foster expansion of gut adult stem cells during calorie restriction.
Cell. 2016;166(2):436–450.
44. Yilmaz ÖH, et al. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature.
2012;486(7404):490–495.
45. Günther C, et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature.
2011;477(7364):335–339.
46. Lu W, de Leeuw E. Functional intersection of human defensin 5 with the TNF receptor pathway. FEBS Lett.
2014;588(10):1906–1912.
47. Van Hauwermeiren F, et al. TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction. Mucosal
Immunol. 2015;8(4):828–840.
48. Schaubeck M, et al. Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis independent of failure in antimicrobial defence. Gut. 2016;65(2):225–237.
49. Roulis M, et al. Host and microbiota interactions are critical for development of murine Crohn’s-like ileitis. Mucosal Immunol.
2016;9(3):787–797.
50. Ooi CJ, et al. Asia Pacific Consensus Statements on Crohn’s disease. Part 1: Definition, diagnosis, and epidemiology: (Asia
Pacific Crohn’s Disease Consensus--Part 1). J Gastroenterol Hepatol. 2016;31(1):45–55.
51. Malhotra R, Turner K, Sonnenberg A, Genta RM. High prevalence of inflammatory bowel disease in United States residents of
Indian ancestry. Clin Gastroenterol Hepatol. 2015;13(4):683–689.
52. Lassen KG, et al. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased
antibacterial defense. Proc Natl Acad Sci USA. 2014;111(21):7741–7746.
53. Murthy A, et al. A Crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3. Nature. 2014;506(7489):456–462.
54. Fuyuno Y, et al. Genetic characteristics of inflammatory bowel disease in a Japanese population. J Gastroenterol.
2016;51(7):672–681.
55. Fava VM, et al. A missense LRRK2 variant is a risk factor for excessive inflammatory responses in leprosy. PLoS Negl Trop Dis.
2016;10(2):e0004412.
56. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469(7330):323–335.
57. Ko Y, Butcher R, Leong RW. Epidemiological studies of migration and environmental risk factors in the inflammatory bowel
diseases. World J Gastroenterol. 2014;20(5):1238–1247.
58. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants
and the indigenous population of Leicestershire. Gut. 1992;33(5):687–693.
59. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and firstand second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol. 1999;94(10):2918–2922.
60. Li X, Sundquist J, Hemminki K, Sundquist K. Risk of inflammatory bowel disease in first- and second-generation immigrants
in Sweden: a nationwide follow-up study. Inflamm Bowel Dis. 2011;17(8):1784–1791.
61. Chuang LS, et al. A frameshift in CSF2RB predominant among Ashkenazi Jews increases risk for Crohn’s disease and reduces
monocyte signaling via GM-CSF. Gastroenterology. 2016;151(4):710–723.e2.
62. Vacic V, et al. Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Hum Mol
Genet. 2014;23(17):4693–4702.

insight.jci.org   https://doi.org/10.1172/jci.insight.91917

13

CLINICAL MEDICINE

63. Verhoef PA, Constantinides MG, McDonald BD, Urban JF, Sperling AI, Bendelac A. Intrinsic functional defects of type 2
innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice. J Allergy
Clin Immunol. 2016;137(2):591–600.e1.
64. Pobezinsky LA, et al. Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol. 2015;16(5):517–524.
65. Sadler AJ, et al. BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs. Proc
Natl Acad Sci USA. 2015;112(5):1535–1540.
66. Soucie EL, et al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells. Science.
2016;351(6274):aad5510.
67. Qi W, Ebbert KV, Craig AW, Greer PA, McCafferty DM. Absence of Fer protein tyrosine kinase exacerbates endotoxin induced
intestinal epithelial barrier dysfunction in vivo. Gut. 2005;54(8):1091–1097.
68. Baxt LA, Xavier RJ. Role of autophagy in the maintenance of intestinal homeostasis. Gastroenterology. 2015;149(3):553–562.
69. Tschurtschenthaler M, et al. Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and
epithelial regeneration. Gut. 2014;63(12):1921–1931.
70. Deuring JJ, et al. Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn’s disease. Gut.
2014;63(7):1081–1091.
71. Lee JC, et al. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn’s
disease. Nat Genet. 2017;49(2):262–268.
72. Matsui T, Hirai F, Hisabe T. Proposed diagnostic criteria for Crohn’s disease. Annual reports of the research group of intractable
inflammatory bowel disease subsidized by the Ministry of Health, Labour, and Welfare of Japan, Tokyo, Japan. 2011;52–54 .
73. Liu TC, Gao F, McGovern DP, Stappenbeck TS. Spatial and temporal stability of paneth cell phenotypes in Crohn’s disease:
implications for prognostic cellular biomarker development. Inflamm Bowel Dis. 2014;20(4):646–651.
74. Takagi S, et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: A randomized-controlled
trial. Aliment Pharmacol Ther. 2006;24(9):1333–1340.
75. Kawai Y, et al. Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese
individuals. J Hum Genet. 2015;60(10):581–587.
76. Nagasaki M, et al. Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat Commun.
2015;6:8018.
77. Yamazaki K, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn’s disease. Hum Mol Genet.
2005;14(22):3499–3506.
78. Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet.
2007;81(3):559–575.
79. Pruim RJ, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics.
2010;26(18):2336–2337.

insight.jci.org   https://doi.org/10.1172/jci.insight.91917

14

